In addition, MYCN amplification inhibits interferon activity and chemokine expression, and its overexpression enhances tumor cell resistance to immune-mediated cytotoxicity through a variety of mechanisms, including MHC-I downregulation and inhibition of NK cell activation (30). This evidence concerns the gene MYCN and neoplasm.